FDA approvals drop 8% in 2025, with fewer blockbusters; Brinsupri, Rhapsido make it to first-in-class list

Data Compilation
#PharmaFlow

Pipeline Prospector February 2026 highlights: Gilead buys Arcellx for US$ 7.8 bn; FDA okays Vanda’s psychotic pill

Stock Recap
#PipelineProspector

Fexofenadine Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

83 API Suppliers, 23 USDMF, 12 CEP/COS, 17 JDMF, 14 EU WC, 13 KDMF, 18 NDC API, 43 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

25 Drugs in Development

25 Drugs in Development

INTERMEDIATES

24 Intermediate Suppliers

24 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

357 FDF Dossiers, 100 FDA Orange Book, 123 Europe, 4 Canada, 5 Australia, 34 South Africa, 91 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SUSPENSION;ORAL - 30MG/5ML, TABLET, EXTENDED RELEASE;ORAL - 60MG;120MG, TABLET;ORAL - 180MG, TABLET;ORAL - 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 60MG, TABLET, EXTENDED RELEASE;ORAL - 180MG;240MG, TABLET, ORALLY DISINTEGRATING;ORAL - 30MG, SUSPENSION;ORAL - 30MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem, 6 Rochem International Inc, 19 SPI Pharma, 2 Pharm-RX Chemical, 10 Boai NKY Pharmaceuticals Ltd, 8 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 2 Pfanstiehl, 9 Kirsch Pharma, 1 Panvo Organics, 4 ACG Worldwide, 12 Actylis, 1 Aeon Procare, 2 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 36 BASF, 1 Bioplus Life Sciences, 2 CD Formulation, 1 Clariant, 11 Corel Pharma Chem, 7 DFE Pharma, 2 Esteem Industries, 2 Finar, 12 Gangwal Chemicals, 2 Gloria Interchem, 1 Huzhou Sunflower Pharmaceutical, 4 Ideal Cures, 5 Ingredion Pharma Solutions, 24 Kerry, 3 Keval Exports, 4 Kima Chemical, 6 Lonza Capsugel, 18 Microlex e.U, 2 Nanjing Bold Chemical, 1 Neelkanth MineChem, 3 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 4 Novo Excipients, 5 Pharmatrans-Sanaq, 8 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 29 Roquette, 13 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 4 Silverline Chemicals, 3 The Dow Chemical Company, 2 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem, 2 Vertellus, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

87 Fillers, Diluents & Binders, 53 Coating Systems & Additives, 49 Direct Compression, 44 Disintegrants & Superdisintegrants, 41 Granulation, 40 Thickeners and Stabilizers, 33 Solubilizers, 32 Taste Masking, 31 Controlled & Modified Release, 27 Lubricants & Glidants, 26 Film Formers & Plasticizers, 25 Chewable & Orodispersible Aids, 25 Parenteral, 21 Topical, 15 Co-Processed Excipients, 10 Emulsifying Agents, 9 Empty Capsules, 8 API Stability Enhancers, 6 Surfactant & Foaming Agents, 6 Rheology Modifiers, 4 Vegetarian Capsules, 2 Coloring Agents

DIGITAL CONTENT

29 News #PharmaBuzz

29 News #PharmaBuzz

GLOBAL SALES INFORMATION

26 Regulatory FDF Prices, 9 Annual Reports

MARKET PLACE

39 APIs, 2 FDF Dossiers

PATENTS & EXCLUSIVITIES

2 US Patents, 19 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 3 USP, 4 JP, 10 Others

ANALYTICAL

1 BioAnalytical Methods, 5 Analytical Methods

$ Xls

Filters

TABLET, ORALLY DISINTEGRATING;ORAL - 30MG

TABLET;ORAL - 30MG

TABLET;ORAL - 180MG

TABLET;ORAL - 60MG

TABLET, EXTENDED RELEASE;ORAL - 180MG;240MG

TABLET, EXTENDED RELEASE;ORAL - 60MG;120MG

SUSPENSION;ORAL - 30MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SUSPENSION;ORAL - 30MG/5ML

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Fexofenadine Hydrochloride

Fexofenadine Hydrochloride

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

83 API Suppliers

23 USDMF

12 CEP/COS

17 JDMF

14 EU WC

13 KDMF

18 NDC API

43 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

25 Drugs in Development

INTERMEDIATES

24 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

357 FDF Dossiers

100 FDA Orange Book

123 Europe

4 Canada

5 Australia

34 South Africa

91 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SUSPENSION;ORAL - 30MG/5ML

TABLET, EXTENDED RELEASE;ORAL - 60MG;120MG

TABLET;ORAL - 180MG

TABLET;ORAL - 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 60MG

TABLET, EXTENDED RELEASE;ORAL - 180MG;240MG

TABLET, ORALLY DISINTEGRATING;ORAL - 30MG

SUSPENSION;ORAL - 30MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem

6 Rochem International Inc

19 SPI Pharma

2 Pharm-RX Chemical

10 Boai NKY Pharmaceuticals Ltd

8 Gangwal Healthcare

7 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

2 Pfanstiehl

9 Kirsch Pharma

1 Panvo Organics

4 ACG Worldwide

12 Actylis

1 Aeon Procare

2 Alcedo Pharmachem

9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 Ashland

36 BASF

1 Bioplus Life Sciences

2 CD Formulation

1 Clariant

11 Corel Pharma Chem

7 DFE Pharma

2 Esteem Industries

2 Finar

12 Gangwal Chemicals

2 Gloria Interchem

1 Huzhou Sunflower Pharmaceutical

4 Ideal Cures

5 Ingredion Pharma Solutions

24 Kerry

3 Keval Exports

4 Kima Chemical

6 Lonza Capsugel

18 Microlex e.U

2 Nanjing Bold Chemical

1 Neelkanth MineChem

3 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

4 Novo Excipients

5 Pharmatrans-Sanaq

8 Pluviaendo

4 Prachin Chemical

TABLET;ORAL - 30MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SUSPENSION;ORAL - 30MG/5ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons